Jay Strum - Chief Scientific Officer, G1 Therapeutics, Inc

As of January 2, 2019


What is Jay Strum's Net Worth?

The current estimated net worth of G1 Therapeutics, Inc's Chief Scientific Officer, Jay Strum, is estimated to be about $1.19M . Jay Strum owns about 48,569 units of G1 Therapeutics, Inc common stock. In the last 2 years at G1 Therapeutics, Inc, Jay Strum has sold an estimated value of $595.97K worth.

What is Jay Strum's Past Insider Trading?

Jay Strum's largest sale order was 10,000 units , worth over $595.97K on August 31, 2018. In total, Jay Strum has made about 5 transactions over 2 years of their time at G1 Therapeutics, Inc. Jay Strum usually trades in January, with the busiest year in 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jay Strum's' Mailing Address?

  • Mailing address is 79 TW Alexander Drive 4501 Research Commons, Suite 100 Research Triangle Park NC 27709 NC

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

What are G1 Therapeutics, Inc's Past Insider Trades?

G1 Therapeutics, Inc's most recent insider trade came on January 5, 2022 by James S Hanson who sold 1,445 units worth $15.33K . In the last 5 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $67.67M and bought an estimated value of $25.7M worth of shares. Insider trading is most common in June and January, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO .

G1 Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1